Latest Form 4 insider transactions

Stella Vnook, a Director of Firefly Neuroscience, Inc., received 84,033 shares of common stock on September 25, 2026.

Brian M Posner, a Director of Firefly Neuroscience, Inc., received 84,033 shares of common stock on September 25, 2026.

Arun Swarup Menawat, a Director of Firefly Neuroscience, Inc., received 126,050 shares of common stock on September 25, 2026.

Thomas Edward Schoenherr, CEO, Diagnostics of Tempus AI, Inc., sold 10,281 shares of common stock on September 25, 2026 for $85.00 per share.

Dion J Weisler, a Director of Thermo Fisher Scientific Inc., received 56 shares of common stock on September 26, 2026.

Scott M Sperling, a Director of Thermo Fisher Scientific Inc., received 63 shares of common stock on September 26, 2026.

Karen S Lynch, a Director of Thermo Fisher Scientific Inc., received 46 shares of common stock on September 26, 2026.

R. Alexandra Keith, a Director of Thermo Fisher Scientific Inc., received 46 shares of common stock on September 26, 2026.

Jennifer M Johnson, a Director of Thermo Fisher Scientific Inc., received 46 shares of common stock on September 26, 2026.

August J. Troendle, President & CEO, a Director and 10% owner of Medpace Holdings, Inc., sold 2,564 shares of common stock on September 25, 2026.

Matthew W. Boddy, SVP, Chief Commerical Officer of Cooper-Standard Holdings Inc., received 4,473 shares of common stock on September 28, 2026.

William C. Werner, EVP, Strategy & Development of BJ's Wholesale Club Holdings, Inc., reported a transaction in 10,007 shares of common stock on September 27, 2026.

Chris Lick, EVP, GENERAL COUNSEL of Scholastic Corp, reported a transaction in 147 shares of common stock on September 28, 2026.

Ka Yip Danny Leung, Interim CEO and CFO of MoneyHero Ltd, received 10,072 shares of common stock on September 25, 2026.

Sasha Quinton, EVP, Pres. CBG of Scholastic Corp, reported a transaction in 1,254 shares of common stock on September 28, 2026.

Iole Lucchese, EVP & CHIEF STRATEGY OFFICER and a Director of Scholastic Corp, reported a transaction in 1,582 shares of common stock on September 28, 2026.

Diana Sacchi, a Director of Helios Technologies, Inc., received 638 shares of common stock on September 25, 2026.

Paul Hukkanen, SVP, CHIEF ACCT OFF of Scholastic Corp, reported a transaction in 434 shares of common stock on September 28, 2026.

Alexander Schuetz, a Director of Helios Technologies, Inc., received 601 shares of common stock on September 25, 2026.

Cary Chenanda, a Director of Helios Technologies, Inc., received 601 shares of common stock on September 25, 2026.

Haojun Wang, Chief Financial Officer of Pony AI Inc., sold 13,751 shares of common stock on September 25, 2026 for $7.10 per share.

Douglas Britt, a Director of Helios Technologies, Inc., received 638 shares of common stock on September 25, 2026.

Alexander William Rossa, Chief Revenue Officer of American Fusion, Inc., purchased 842,775 shares of common stock on September 22, 2026 for $0.10 per share.

Laura D Brown, a Director of Helios Technologies, Inc., received 951 shares of common stock on September 25, 2026.

Ian K. Walsh, a Director of Helios Technologies, Inc., received 565 shares of common stock on September 25, 2026.

Michael Ray Anderson, CEO, President & director and a Director of National Healthcare Properties, Inc., reported a transaction in 16,041 shares of common stock on September 27, 2026.

Lori Wittman, a Director of Armada Hoffler Properties, Inc., purchased 3,000 shares of common stock on September 28, 2026 for $5.95 per share.

Ning Zhang, Vice President of Pony AI Inc., sold 15,524 shares of common stock on September 25, 2026 for $7.10 per share.

Andrew Dakos, President and CEO and a Director of Swiss Helvetia Fund, Inc., purchased 20,000 shares of common stock on September 25, 2026.

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on September 25, 2026.